Phil Shackley BA MSc PhD
Reader in Health Economics
University of Sheffield
Regent Court, 30 Regent Street
Sheffield, S1 4DA
Tel: (+44) (0)114 222 2992
Fax: (+44) (0)114 222 0749
I was appointed Reader in Health Economics in January 2012, having previously held Senior Lecturer appointments at the Universities of Sheffield (2006-2011) and Newcastle (2002-2006). Prior to that I worked as a Lecturer at the University of Sheffield (1996–2002) and as a Research Fellow at the University of Aberdeen (1991–1996).
- Developing and applying the contingent valuation methodology, in particular the technique of willingness to pay. Applications include: estimating the social value of a quality adjusted life year (QALY); using willingness to pay values to aid priority setting in publicly-financed health care systems; investigating how willingness to pay can and should be used alongside randomised trials; the use of willingness to pay to evaluate the benefits of public health interventions such as the fluoridation of drinking water supplies and the supplementation of flour with folic acid; evaluating minimally invasive surgery; assessing patient preferences for diagnostic radiology; and assessing preferences for an expanded newborn screening programme.
- The identification, measurement and valuation of (dis)benefits that are not captured in the QALY approach. Applications include: assessing the value of patient health cards; eliciting patient preferences for out-of-hours primary care services; establishing and quantifying the preferences of mental health service users for day hospital care; eliciting patient preferences for the organisation of vascular services; and assessing preferences for access to a general practitioner.
- The application of economic evaluation techniques to assess the efficiency of health care programmes and interventions. Applications include: screening in primary care; antenatal screening; management of lower respiratory tract infection in general practice; computerised cognitive behavioural therapy for anxiety and depression; methods for assessing patients with intermittent claudication; drug treatments for epilepsy; stroke incidence and prevention in Tanzania; venous leg ulcers; and treating upper limb spasticity due to stroke with botulinum toxin.
I teach health economics on a number of modules on MSc Health Economics and Decision Modelling, MSc Economics and Health Economics and MSc International Health Technology Assessment, Pricing and Reimbursement. I am the Director of Teaching for HEDS and the Academic Lead for Teaching Quality for ScHARR.
I am interested in supervising research students in topics related to my research interests above.
- Member of the Higher Education Academy (formerly the Institute for Learning and Teaching in Higher Education)
- Member of the UK Health Economists' Study Group
- Member of the International Health Economics Association
- Examining the feasibility of measuring process utilities associated with different models of care for obese leg ulcer patients.
- The design, development, commissioning and evaluation of patient focused vascular services.
- Evaluation of workplace interventions for long latency diseases.
Phil Shackley is based in Health Economics and Decision Science (HEDS).
- Rowen D, Brazier J, Mukuria C, Keetharuth A, Risa Hole A, Tsuchiya A, Whyte S & Shackley P (2016) Eliciting Societal Preferences for Weighting QALYs for Burden of Illness and End of Life. Medical Decision Making, 36(2), 210-222.
- Shackley P & Dixon S (2013) The random card sort method and respondent certainty in contingent valuation: An exploratory investigation of range bias. Health Economics (United Kingdom).
- Shackley P, Shaw L, Price C, van Wijck F, Barnes M, Graham L, Ford GA, Steen N & Rodgers H (2012) Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type a: Results from the botulinum toxin for the upper limb after stroke (BoTULS) trial. Toxins, 4(12), 1415-1426. View this article in WRRO
- Donaldson C, Baker R, Mason H, Jones-Lee M, Lancsar E, Wildman J, Bateman I, Loomes G, Robinson A, Sugden R , Prades JLP et al (2011) The social value of a QALY: raising the bar or barring the raise?. BMC Health Serv Res, 11, 8. View this article in WRRO
- Shaw LC, Price CIM, van Wijck FMJ, Shackley P, Steen N, Barnes MP, Ford GA, Graham LA, Rodgers H & BoTULS Investigators (2011) Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.. Stroke, 42(5), 1371-1379.
- Michaels JA, Campbell B, King B, Palfreyman SJ, Shackley P & Stevenson M (2009) Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial).. Br J Surg, 96(10), 1147-1156.
- Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J , Eaton B et al (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1016-1026.
- Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J , Eaton B et al (2007) The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. LANCET, 369(9566), 1000-1015.
- Shackley P & Donaldson C (2002) Should we use willingness to pay to elicit community preferences for health care? New evidence from using a 'marginal' approach.. J Health Econ, 21(6), 971-991.
- Stewart JM, O'Shea E, Donaldson C & Shackley P (2002) Do ordering effects matter in willingness-to-pay studies of health care?. J Health Econ, 21(4), 585-599.